1. Prevalence, Pattern, and Correlates of Polypharmacy among Iranian Type II Diabetic Patients: Results from Pars Cohort Study

Mahbobeh Azadi , Alireza Kamalipour, Hossein Molavi Vardanjani* , Hossein Poustchi, Erfan Taherifard, Mohammad Hossein Sharifi, Alireza Salehi, Zahra Mohammadi

Arch Iran Med. 2021;24(9): 657-664. doi: 10.34172/aim.2021.94

Scopus ID: 85117387903

Article

PDF

XML

Cited By:

Original Article

2. Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study

Mohammad Reza Akbari , Alireza Kamalipour , Mahsa Pakroo, Bita Mesgarpour , Hossein Poustchi, Zahra Mohammadi, Abdullah Gandomkar, Hossein Molavi Vardanjani*

Arch Iran Med. 2023;26(3): 156-165. doi: 10.34172/aim.2023.24

PMCID: PMC10685724 PMID: 37543938

Article

PDF

Suppl 1

XML

Cited By:

Original Article

3. Assessment of Hemoglobin A1c Management and Prescription Cost Due to Polypharmacy Among Patients With Diabetes in Iran Based on the STEPS Iran 2016 Survey and a Prescription Database: A Multi-level, Cross-sectional National Study

Mojdeh Daneshmand , Hamidreza Jamshidi* , Mohammad Hadi Farjoo, Mohammad Reza Malekpour, Erfan Ghasemi, Seyede Salehe Mortazavi, Mohsen Shati, Farshad Farzadfar

Arch Iran Med. 2024;27(1): 1-7. doi: 10.34172/aim.2024.01

PMCID: PMC10915928 PMID: 38431954

Article

PDF

XML

Cited By:

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.